The clinical impact of the universal diagnosis of myocardial infarction

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: All of the recent guidelines now endorse the use of troponin as the biomarker or choice for the diagnosis of acute myocardial infarction (AMI). Methods: Review of the recent guidelines criteria. Results: Rising and/or falling values of troponin in patients who appear to have ischemic heart disease will result in the diagnosis of AMI. The recent guidelines emphasize the use of the 99th percentile value for troponin and suggest it should be measurable with a high level of precision. They also suggest how to operationalize determining a significant change for patients who appear to have recurrent infarction and classify AMI into five subtypes. Conclusions: Understanding these criteria will be important to a consistent approach to the diagnosis of AMI in the future.

Original languageEnglish (US)
Pages (from-to)1485-1488
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume46
Issue number11
DOIs
StatePublished - Nov 1 2008

Fingerprint

Troponin
Myocardial Infarction
Guidelines
Accidental Falls
Biomarkers
Infarction
Myocardial Ischemia

Keywords

  • Myocardial infarction
  • Troponin
  • Universal

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The clinical impact of the universal diagnosis of myocardial infarction. / Jaffe, Allan S.

In: Clinical Chemistry and Laboratory Medicine, Vol. 46, No. 11, 01.11.2008, p. 1485-1488.

Research output: Contribution to journalArticle

@article{61df06f92f524029a27ae33dbd93d716,
title = "The clinical impact of the universal diagnosis of myocardial infarction",
abstract = "Background: All of the recent guidelines now endorse the use of troponin as the biomarker or choice for the diagnosis of acute myocardial infarction (AMI). Methods: Review of the recent guidelines criteria. Results: Rising and/or falling values of troponin in patients who appear to have ischemic heart disease will result in the diagnosis of AMI. The recent guidelines emphasize the use of the 99th percentile value for troponin and suggest it should be measurable with a high level of precision. They also suggest how to operationalize determining a significant change for patients who appear to have recurrent infarction and classify AMI into five subtypes. Conclusions: Understanding these criteria will be important to a consistent approach to the diagnosis of AMI in the future.",
keywords = "Myocardial infarction, Troponin, Universal",
author = "Jaffe, {Allan S}",
year = "2008",
month = "11",
day = "1",
doi = "10.1515/CCLM.2008.296",
language = "English (US)",
volume = "46",
pages = "1485--1488",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "11",

}

TY - JOUR

T1 - The clinical impact of the universal diagnosis of myocardial infarction

AU - Jaffe, Allan S

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background: All of the recent guidelines now endorse the use of troponin as the biomarker or choice for the diagnosis of acute myocardial infarction (AMI). Methods: Review of the recent guidelines criteria. Results: Rising and/or falling values of troponin in patients who appear to have ischemic heart disease will result in the diagnosis of AMI. The recent guidelines emphasize the use of the 99th percentile value for troponin and suggest it should be measurable with a high level of precision. They also suggest how to operationalize determining a significant change for patients who appear to have recurrent infarction and classify AMI into five subtypes. Conclusions: Understanding these criteria will be important to a consistent approach to the diagnosis of AMI in the future.

AB - Background: All of the recent guidelines now endorse the use of troponin as the biomarker or choice for the diagnosis of acute myocardial infarction (AMI). Methods: Review of the recent guidelines criteria. Results: Rising and/or falling values of troponin in patients who appear to have ischemic heart disease will result in the diagnosis of AMI. The recent guidelines emphasize the use of the 99th percentile value for troponin and suggest it should be measurable with a high level of precision. They also suggest how to operationalize determining a significant change for patients who appear to have recurrent infarction and classify AMI into five subtypes. Conclusions: Understanding these criteria will be important to a consistent approach to the diagnosis of AMI in the future.

KW - Myocardial infarction

KW - Troponin

KW - Universal

UR - http://www.scopus.com/inward/record.url?scp=56549096027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56549096027&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2008.296

DO - 10.1515/CCLM.2008.296

M3 - Article

C2 - 19012516

AN - SCOPUS:56549096027

VL - 46

SP - 1485

EP - 1488

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 11

ER -